ObsEva SA Analysis
| OBSVDelisted Stock | USD 0.08 0 5.00% |
ObsEva SA is overvalued with Real Value of 0.0798 and Hype Value of 0.08. The main objective of ObsEva SA delisted stock analysis is to determine its intrinsic value, which is an estimate of what ObsEva SA is worth, separate from its market price. There are two main types of ObsEva SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ObsEva SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ObsEva SA's stock to identify patterns and trends that may indicate its future price movements.
The ObsEva SA stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ObsEva SA is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. ObsEva Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ObsEva SA's ongoing operational relationships across important fundamental and technical indicators.
ObsEva |
ObsEva Stock Analysis Notes
About 13.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.72. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ObsEva SA recorded a loss per share of 0.74. The entity had not issued any dividends in recent years. The firm had 13:1 split on the 6th of December 2016. ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland. Obseva Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. To find out more about ObsEva SA contact Ernest Loumaye at 41 22 552 38 40 or learn more at https://www.obseva.com.ObsEva SA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ObsEva SA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ObsEva SA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ObsEva SA is not yet fully synchronised with the market data | |
| ObsEva SA has some characteristics of a very speculative penny stock | |
| ObsEva SA has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.64 M. Net Loss for the year was (29.88 M) with profit before overhead, payroll, taxes, and interest of 17 K. | |
| ObsEva SA currently holds about 14.13 M in cash with (23.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
ObsEva SA Upcoming and Recent Events
Earnings reports are used by ObsEva SA to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ObsEva SA previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 23rd of March 2023 Upcoming Quarterly Report | View | |
| 16th of May 2023 Next Financial Report | View | |
| 31st of December 2022 Next Fiscal Quarter End | View | |
| 23rd of March 2023 Next Fiscal Year End | View | |
| 30th of September 2022 Last Quarter Report | View | |
| 31st of December 2021 Last Financial Announcement | View |
ObsEva Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ObsEva SA's market, we take the total number of its shares issued and multiply it by ObsEva SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.ObsEva SA Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ObsEva SA insiders, such as employees or executives, is commonly permitted as long as it does not rely on ObsEva SA's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ObsEva SA insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ernest Loumaye over a year ago Purchase by Ernest Loumaye of 4000000 shares of ObsEva SA | ||
William Brown over a year ago Acquisition by William Brown of 250000 shares of ObsEva SA subject to Rule 16b-3 | ||
Ernest Loumaye over a year ago ObsEva SA exotic insider transaction detected |
ObsEva SA Predictive Daily Indicators
ObsEva SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ObsEva SA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About ObsEva Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how ObsEva SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ObsEva shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as ObsEva SA. By using and applying ObsEva Stock analysis, traders can create a robust methodology for identifying ObsEva entry and exit points for their positions.
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland. Obseva Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ObsEva SA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in ObsEva Stock
If you are still planning to invest in ObsEva SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ObsEva SA's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |